Savant Capital, LLC Becton Dickinson & CO Transaction History

Savant Capital, LLC

  • $17.8 Billion
  • Q3 2025

A detailed history of Savant Capital, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Savant Capital, LLC holds 21,224 shares of BDX stock, worth $4.05 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,224
Previous 13,836 53.4%
Holding current value
$4.05 Million
Previous $2.38 Million 66.68%
% of portfolio
0.02%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
BUY
$172.41 - $199.66 $1.27 Million - $1.48 Million
7,388 Added 53.4%
21,224 $3.97 Million
Q2 2025

Aug 06, 2025
BUY
$165.15 - $226.42 $146,983 - $201,513
890 Added 6.87%
13,836 $2.38 Million
Q1 2025

May 08, 2025
SELL
$222.79 - $249.08 $374,732 - $418,952
-1,682 Reduced 11.5%
12,946 $2.97 Million
Q4 2024

Jan 28, 2025
BUY
$220.02 - $243.75 $1.49 Million - $1.65 Million
6,759 Added 85.89%
14,628 $3.32 Million
Q3 2024

Nov 04, 2024
BUY
$221.47 - $242.41 $331,540 - $362,887
1,497 Added 23.49%
7,869 $1.9 Million
Q2 2024

Aug 05, 2024
SELL
$225.07 - $246.17 $418,630 - $457,876
-1,860 Reduced 22.59%
6,372 $1.49 Million
Q1 2024

May 03, 2024
BUY
$233.45 - $247.73 $76,805 - $81,503
329 Added 4.16%
8,232 $2.04 Million
Q4 2023

Feb 05, 2024
BUY
$232.24 - $267.23 $699,506 - $804,896
3,012 Added 61.58%
7,903 $1.93 Million
Q3 2023

Nov 06, 2023
BUY
$254.9 - $283.59 $109,607 - $121,943
430 Added 9.64%
4,891 $1.26 Million
Q2 2023

Aug 04, 2023
BUY
$238.39 - $265.32 $147,563 - $164,233
619 Added 16.11%
4,461 $1.18 Million
Q1 2023

May 02, 2023
BUY
$229.71 - $259.35 $28,943 - $32,678
126 Added 3.39%
3,842 $951,000
Q4 2022

Feb 06, 2023
BUY
$218.29 - $256.91 $305,169 - $359,160
1,398 Added 60.31%
3,716 $945,000
Q3 2022

Oct 28, 2022
BUY
$51.03 - $264.23 $10,103 - $52,317
198 Added 9.34%
2,318 $517,000
Q2 2022

Jul 22, 2022
SELL
$234.74 - $275.42 $64,084 - $75,189
-273 Reduced 11.41%
2,120 $523,000
Q1 2022

May 05, 2022
BUY
$243.64 - $270.48 $60,179 - $66,808
247 Added 11.51%
2,393 $637,000
Q4 2021

Feb 08, 2022
BUY
$230.08 - $250.94 $43,715 - $47,678
190 Added 9.71%
2,146 $540,000
Q3 2021

Nov 12, 2021
BUY
$232.72 - $256.47 $33,744 - $37,188
145 Added 8.01%
1,956 $481,000
Q2 2021

Aug 04, 2021
SELL
$232.65 - $254.58 $6,979 - $7,637
-30 Reduced 1.63%
1,811 $440,000
Q1 2021

May 04, 2021
SELL
$232.09 - $256.88 $36,438 - $40,330
-157 Reduced 7.86%
1,841 $448,000
Q4 2020

Feb 03, 2021
SELL
$221.92 - $245.94 $23,301 - $25,823
-105 Reduced 4.99%
1,998 $500,000
Q3 2020

Nov 04, 2020
SELL
$215.77 - $276.76 $118,673 - $152,218
-550 Reduced 20.73%
2,103 $489,000
Q2 2020

Aug 11, 2020
SELL
$219.9 - $263.41 $19,571 - $23,443
-89 Reduced 3.25%
2,653 $635,000
Q1 2020

Apr 30, 2020
BUY
$195.69 - $279.01 $51,075 - $72,821
261 Added 10.52%
2,742 $630,000
Q4 2019

Jan 31, 2020
BUY
$236.45 - $266.82 $945 - $1,067
4 Added 0.16%
2,481 $675,000
Q3 2019

Nov 12, 2019
BUY
$230.58 - $256.08 $6,686 - $7,426
29 Added 1.18%
2,477 $627,000
Q2 2019

Aug 06, 2019
SELL
$217.4 - $246.08 $8,696 - $9,843
-40 Reduced 1.61%
2,448 $617,000
Q1 2019

May 02, 2019
BUY
$206.05 - $248.17 $16,690 - $20,101
81 Added 3.37%
2,488 $621,000
Q4 2018

Feb 05, 2019
SELL
$204.73 - $257.93 $33,780 - $42,558
-165 Reduced 6.42%
2,407 $542,000
Q3 2018

Oct 23, 2018
SELL
$233.07 - $256.0 $15,149 - $16,640
-65 Reduced 2.46%
2,572 $671,000
Q2 2018

Aug 07, 2018
SELL
$208.1 - $233.85 $3,121 - $3,507
-15 Reduced 0.57%
2,637 $632,000
Q1 2018

Apr 27, 2018
BUY
$205.46 - $240.27 $235,457 - $275,349
1,146 Added 76.1%
2,652 $575,000
Q3 2017

Oct 31, 2017
BUY
$186.89 - $198.9 $281,456 - $299,543
1,506
1,506 $295,000

Others Institutions Holding BDX

# of Institutions
1,717
Shares Held
257M
Call Options Held
1.01M
Put Options Held
544K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $54.5B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email